.png)
CardiaTec: Revolutionising Heart Health
CardiaTec is at the forefront of drug development for cardiovascular diseases. Through sequencing and AI, they are generating the largest multiomics dataset surrounding human hearts to uncover novel therapeutics.
Lucy Ahern
November 7, 2024
Meatly: The First APHA Approved Cultivated Meat in Europe
Cultivated or cultured meat is an exciting technology that provides an alternative to traditional farmed, animal meat. It has various advantages in environmental impact, animal welfare, and more. Meatly is a start-up producing cultivated, lab-grown meat and what sets them apart is that they specialise in producing pet food.
Sandeep Mangrati
October 30, 2024
Kadence Bio Pioneers Innovative Therapies for Sexual and Mental Health
Kadence Bio (formerly Kanna Health) is a clinical-stage drug development company pioneering new treatments for sexual health. Their lead asset, KH-001, is being developed as the first FDA-approved treatment for premature ejaculation. The company recently completed a Phase I clinical trial and is planning to initiate Phase II trials next year.
Laura Castillo De Franca
October 10, 2024
SEC Launches Cohort V of the Innovators Club Welcoming Eight Life Science Start-ups
London, September 2024 - The Innovators Club, a network accelerator programme run by the Science Entrepreneur Club (SEC), has today announced its fifth cohort welcoming eight life science start-ups.
Matthew McCann
September 19, 2024
SEC and SPARK Partner to Launch BioEntrepreneur Club Midlands Chapter
The SEC and SPARK have joined forces to launch a Midlands chapter of the SEC’s BioEntrepreneur Club, a collaborative and supportive peer-to-peer community exclusively for founders and C-suite in the life sciences.
Matthew McCann
September 10, 2024
Punto Health: The Dementia Care Revolution
A dementia diagnosis can leave people feeling adrift and alone. They’re often left with mounds of questions but very limited access to personalised information or specialists. We had the opportunity to speak to Anna Muñoz Farré, founder and CEO of Punto Health, about how they are starting a dementia care revolution.
Megan Thomas
August 7, 2024
From Sugar to Surgery: The Evolution of Obesity in Plain Sight
Over two decades ago, the World Health Organization (WHO) sounded the alarm on obesity, declaring it a global epidemic. Fast forward to 2013, and the WHO set an ambitious goal: halt the rise in obesity by 2030. But with just six years left, the numbers tell a different story...
George William Ssendagala
July 11, 2024
.png)
What’s hot in biomaterials, according to investors
To find out investor’s thoughts on the biomaterials sector, we spoke to three members of our BioCapital Network; Sarah Jones - Principal at Zero Carbon Capital, Elisabetta Sakiotis - Analyst at Rockstart, and Josh Armistead-Wood - Senior Associate at Sustainable Ventures.
June 27, 2024
BoobyBiome: Pioneering Infant Health Innovation.
BoobyBiome, a start-up innovating the realm of infant health, is spearheading efforts to redefine neonatal care through a deep understanding of the gut microbiome. Founded by Lydia, Sioned, and Tara, they are dedicated to leveraging cutting-edge science to optimise infant health outcomes, particularly focusing on premature infants.
Joanna Myślińska
June 19, 2024
Biomaterials: Are they the answer to our sustainability issues?
Whilst biomaterials are entering an exciting era within regenerative medicine, it has become clear the translation of principles across industries has opened the door for biomaterials to heal the planet. In this article we showcase creative interpretations of a biomaterial and their range of potential applications in a strive towards more sustainable products.
June 12, 2024